Research in amyotrophic lateral sclerosis: What is new in 2009?;La recherche sur la SLA en 2009: compte rendu du groupe bibliographique de la coordination des centres SLA

Revue Neurologique

Volumn 166, Issue 8-9, 2010, Pages 683-698

  Pradat, P F ^a   Attarian, S ^b   Camdessanche J P ^c   Carluer, L ^d   Cintas, P ^e   Corcia, P ^f   Echaniz Laguna, A ^g   Gonzalez Bermejo, J ^a   Guy, N ^h   Nicolas, G ⁱ   Perez, T ^j   Soriani, M H ^k   Vandenberghe, N ^l   Verschueren, A ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL NORD   (France)

^d CHU CÔTE DE NACRE   (France)

^e CHU RANGUEIL   (France)

^f CHU BRETONNEAU   (France)

^g HÔPITAL CIVIL   (France)

^h SERVICE DE RHUMATOLOGIE   (France)

ⁱ ANGERS UNIVERSITY HOSPITAL   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^l HÔPITAL NEUROLOGIQUE   (France)

more..

Author keywords

ALS; Animals models; DFT; FUS TLS; Neuroprotection; SOD1

Indexed keywords

FORMALDEHYDE; GLATIRAMER; LITHIUM; SOMATOMEDIN C; UBIQUINONE; UBIQUITIN; VALPROIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL RESEARCH; ENDOPLASMIC RETICULUM STRESS; ENVIRONMENTAL FACTOR; FRONTAL LOBE; GENE CONTROL; GENE MUTATION; GENETIC LINKAGE; HUMAN; LIPID PEROXIDATION; METABOLIC DISORDER; MOTONEURON; MOTOR DYSFUNCTION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RNA SPLICING; RNA TRANSCRIPTION; RNA TRANSPORT; SMOKING; TEMPORAL LOBE;

EID: 77955984158     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2010.03.006     Document Type: Review

References (117)

1. F. Agosta, M.A. Rocca, P. Valsasina, S. Sala, D. Caputo, and M. Perini A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients J Neurol Neurosurg Psychiatry 80 2009 53 55
2. C. Armon Smoking may be considered an established risk factor for sporadic ALS Neurology 73 2009 1693 1698
3. I. Arnulf, T. Similowski, F. Salachas, L. Garma, S. Mehiri, and V. Attali Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis Am J Respir Crit Care Med 161 2000 849 856
4. S. Attarian, J. Pouget, and A. Schmied Changes in cortically induced inhibition in amyotrophic lateral sclerosis with time Muscle Nerve 39 2009 310 317
5. Beggs K, Choi M, Travlos A. Assessing and predicting successful tube placement outcomes in ALS patients. Amyotroph Lateral Scler 2010:1-4, doi:10.1080/17482960903207377.
6. V.V. Belzil, P.N. Valdmanis, P.A. Dion, H. Daoud, E. Kabashi, and A. Noreau Mutations in FUS cause FALS and SALS in French and French Canadian populations Neurology 73 2009 1176 1179
7. Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, Manavis J, et al. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry 2010, doi:10.1136/jnnp.2009.194399.
8. G.D. Borasio, W. Robberecht, P.N. Leigh, J. Emile, R.J. Guiloff, and F. Jerusalem A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis Neurology 51 1998 583 586
9. S.C. Bourke, M. Tomlinson, T.L. Williams, R.E. Bullock, P.J. Shaw, and G.J. Gibson Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial Lancet Neurol 5 2006 140 147
10. C. Bouteloup, J.C. Desport, P. Clavelou, N. Guy, H. Derumeaux-Burel, and A. Ferrier Hypermetabolism in ALS patients: an early and persistent phenomenon J Neurol 256 2009 1236 1242
11. J.N. Burrow, and P.C. Blumbergs Substantia nigra degeneration in motor neurone disease: a quantitative study Aust N Z J Med 22 1992 469 472
12. P. Carratu, L. Spicuzza, A. Cassano, M. Maniscalco, F. Gadaleta, and D. Lacedonia Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency Orphanet J Rare Dis 4 2009 10
13. B.C. Cheah, R.A. Boland, N.E. Brodaty, M.C. Zoing, S.E. Jeffery, and D.K. McKenzie INSPIRATIonAL-INSPIRAtory muscle training in amyotrophic lateral sclerosis Amyotroph Lateral Scler 10 2009 384 392
14. A. Chio, G. Benzi, M. Dossena, R. Mutani, and G. Mora Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players Brain 128 2005 472 476
15. A. Chio, G. Mora, A. Calvo, L. Mazzini, E. Bottacchi, and R. Mutani Epidemiology of ALS in Italy: a 10-year prospective population-based study Neurology 72 2009 725 731
16. A. Chio, A. Calvo, M. Dossena, P. Ghiglione, R. Mutani, and G. Mora ALS in Italian professional soccer players: the risk is still present and could be soccer-specific Amyotroph Lateral Scler 10 2009 205 209
17. A. Chio, A. Calvo, A. Ilardi, E. Cavallo, C. Moglia, and R. Mutani Lower serum lipid levels are related to respiratory impairment in patients with ALS Neurology 73 2009 1681 1685
18. I.M. Chiu, A. Chen, Y. Zheng, B. Kosaras, S.A. Tsiftsoglou, and T.K. Vartanian T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS Proc Natl Acad Sci U S A 105 2008 17913 17918
19. V. Cima, G. Logroscino, C. D'Ascenzo, A. Palmieri, M. Volpe, and C. Briani Epidemiology of ALS in Padova district, Italy, from 1992 to 2005 Eur J Neurol 16 2009 920 924
20. P. Corcia, P.F. Pradat, F. Salachas, G. Bruneteau, N.L. Forestier, and D. Seilhean Causes of death in a post-mortem series of ALS patients Amyotroph Lateral Scler 9 2008 59 62
21. L. Corrado, R. Del Bo, and B. Castellotti Mutations of FUS gene in sporadic amyotrophic lateral sclerosis J Med Genet. 47 2010 190 194
22. C. Crochemore, M. Virgili, B. Bonamassa, D. Canistro, E. Pena-Altamira, and M. Paolini Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model for amyotrophic lateral sclerosis Muscle Nerve 39 2009 548 552
23. S. Cronin, O. Hardiman, and B.J. Traynor Ethnic variation in the incidence of ALS: a systematic review Neurology 68 2007 1002 1007
24. K.P. Czudaj, S. Suchi, and B. Schonhofer Physiological parameters of breathing and the impact of non-invasive ventilation (NIV) on patients with amyotrophic lateral sclerosis (ALS) Pneumologie 63 2009 687 692
25. V. Dalbello-Haas, J.M. Florence, and L.S. Krivickas Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease Cochrane Database Syst Rev 2008 CD005229
26. M. de Carvalho, R. Dengler, A. Eisen, J.D. England, R. Kaji, and J. Kimura Electrodiagnostic criteria for diagnosis of ALS Clin Neurophysiol 119 2008 497 503
27. H. Deda, M.C. Inci, A.E. Kurekci, A. Sav, K. Kayihan, and E. Ozgun Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up Cytotherapy 11 2009 18 25
28. S. Deforges, J. Branchu, O. Biondi, C. Grondard, C. Pariset, and S. Lecolle Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis J Physiol 587 2009 3561 3572
29. V. Di Lazzaro, F. Pilato, P. Profice, F. Ranieri, G. Musumeci, and L. Florio Motor cortex stimulation for ALS: a double blind placebo-controlled study Neurosci Lett 464 2009 18 21
30. L. Dupuis, P. Corcia, A. Fergani, J.L. Gonzalez de Aguilar, D. Bonnefont-Rousselot, and R. Bittar Dyslipidemia is a protective factor in amyotrophic lateral sclerosis Neurology 70 2008 1004 1009
31. L. Dupuis, F. Di Scala, F. Rene, M. de Tapia, H. Oudart, and P.F. Pradat Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis FASEB J 17 2003 2091 2093
32. L. Dupuis, J.L. Gonzalez de Aguilar, A. Echaniz-Laguna, J. Eschbach, F. Rene, and H. Oudart Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons PLoS ONE 4 2009 e5390
33. L. Dupuis, and J.P. Loeffler Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models Curr Opin Pharmacol 9 2009 341 346
34. F. Fang, U. Valdimarsdottir, R. Bellocco, L.O. Ronnevi, P. Sparen, and K. Fall Amyotrophic lateral sclerosis in Sweden, 1991-2005 Arch Neurol 66 2009 515 519
35. H.L. Feng, Y. Leng, C.H. Ma, J. Zhang, M. Ren, and D.M. Chuang Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model Neuroscience 155 2008 567 572
36. A.G. Floyd, Q.P. Yu, P. Piboolnurak, M.X. Tang, Y. Fang, and W.A. Smith Transcranial magnetic stimulation in ALS: utility of central motor conduction tests Neurology 72 2009 498 504
37. M.S. Forman, J.Q. Trojanowski, and V.M. Lee TDP-43: a novel neurodegenerative proteinopathy Curr Opin Neurobiol 17 2007 548 555
38. F. Fornai, P. Longone, L. Cafaro, O. Kastsiuchenka, M. Ferrucci, and M.L. Manca Lithium delays progression of amyotrophic lateral sclerosis Proc Natl Acad Sci U S A 105 2008 2052 2057
39. B. Funalot, J.C. Desport, F. Sturtz, W. Camu, and P. Couratier High metabolic level in patients with familial amyotrophic lateral sclerosis Amyotroph Lateral Scler 10 2009 113 117
40. V. Gallo, H.B. Bueno-De-Mesquita, R. Vermeulen, P.M. Andersen, A. Kyrozis, and J. Linseisen Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort Ann Neurol 65 2009 378 385
41. F. Geser, M. Martinez-Lage, L.K. Kwong, V.M. Lee, and J.Q. Trojanowski Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases J Neurol 256 2009 1205 1214
42. J. Gil, B. Funalot, A. Verschueren, V. Danel-Brunaud, W. Camu, and N. Vandenberghe Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study Eur J Neurol 15 2008 1245 1251
43. A. Gill, J. Kidd, F. Vieira, K. Thompson, and S. Perrin No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS PLoS ONE 4 2009 e6489
44. E.F. Goodall, M.S. Haque, and K.E. Morrison Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients J Neurol 255 2008 1652 1656
45. J.S. Henkel, D.R. Beers, W. Zhao, and S.H. Appel Microglia in ALS: the good, the bad, and the resting J Neuroimmune Pharmacol 4 2009 389 398
46. K. Ito, H. Chitose, and A. Kobayashi Upper airway obstruction caused by a floppy epiglottis - report of two cases of amyotrophic lateral sclerosis (ALS) Nippon Jibiinkoka Gakkai Kaiho 112 2009 660 664
47. Y. Ito, M. Yamada, H. Tanaka, K. Aida, K. Tsuruma, and M. Shimazawa Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice Neurobiol Dis 36 2009 470 476
48. C.E. Jackson, G. Gronseth, J. Rosenfeld, R.J. Barohn, R. Dubinsky, and C.B. Simpson Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients Muscle Nerve 39 2009 137 143
49. N. Just, N. Bautin, and V. Danel-Brunaud The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis Eur Respir J. 35 2010 353 360
50. E. Kabashi, P.N. Valdmanis, P. Dion, D. Spiegelman, B.J. McConkey, and V.C. Vande TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis Nat Genet 40 2008 572 574
51. T. Kasai, T. Tokuda, N. Ishigami, H. Sasayama, P. Foulds, and D.J. Mitchell Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis Acta Neuropathol 117 2009 55 62
52. P. Kaufmann, J.L. Thompson, G. Levy, R. Buchsbaum, J. Shefner, and L.S. Krivickas Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III Ann Neurol 66 2009 235 244
53. M. Kawajiri, M. Mogi, N. Higaki, T. Tateishi, Y. Ohyagi, and M. Horiuchi Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis Acta Neurol Scand 119 2009 341 344
54. M. Kawajiri, M. Mogi, N. Higaki, T. Matsuoka, Y. Ohyagi, and K. Tsukuda Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis Mult Scler 15 2009 262 265
55. L. Kheifets, J.D. Bowman, H. Checkoway, M. Feychting, J.M. Harrington, and R. Kavet Future needs of occupational epidemiology of extremely low frequency electric and magnetic fields: review and recommendations Occup Environ Med 66 2009 72 80
56. C. Konrad, H. Henningsen, J. Bremer, B. Mock, M. Deppe, and C. Buchinger Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study Exp Brain Res 143 2002 51 56
57. J. Kuhle, R.L. Lindberg, A. Regeniter, M. Mehling, A.J. Steck, and L. Kappos Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis Eur J Neurol 16 2009 771 774
58. K.M. Kurian, R.B. Forbes, S. Colville, and R.J. Swingler Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register J Neurol Neurosurg Psychiatry 80 2009 84 87
59. E.C. Lai, K.J. Felice, B.W. Festoff, M.J. Gawel, D.F. Gelinas, and R. Kratz Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study Neurology 49 1997 1621 1630
60. D. Lewis, M.A. Ampong, A. Rio, E. Willey, J. Johnson, and C.E. Shaw Mushroom-cage gastrostomy tube placement in patients with amyotrophic lateral sclerosis: a 5-year experience in 104 patients in a single institution Eur Radiol 19 2009 1763 1771
61. H.N. Liu, T. Sanelli, P. Horne, E.P. Pioro, M.J. Strong, and E. Rogaeva Lack of evidence of monomer/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis Ann Neurol 66 2009 75 80
62. Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010, doi:10.1136/jnnp.2009.183525.
63. B. Marin, J. Gil, P.M. Preux, B. Funalot, and P. Couratier Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007 Amyotroph Lateral Scler 10 2009 216 220
64. H.R. Martinez, M.T. Gonzalez-Garza, J.E. Moreno-Cuevas, E. Caro, E. Gutierrez-Jimenez, and J.J. Segura Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients Cytotherapy 11 2009 26 34
65. R.T. Matthews, L. Yang, S. Browne, M. Baik, and M.F. Beal Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects Proc Natl Acad Sci U S A 95 1998 8892 8897
66. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A phase I clinical trial. Exp Neurol 2010, doi:10.1016/j.expneurol.2009.08.007.
67. L. Mazzini, K. Mareschi, I. Ferrero, E. Vassallo, G. Oliveri, and N. Nasuelli Stem cell treatment in Amyotrophic Lateral Sclerosis J Neurol Sci 265 2008 78 83
68. V. Meininger, V.E. Drory, P.N. Leigh, A. Ludolph, W. Robberecht, and V. Silani Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial Amyotroph Lateral Scler 10 2009 378 383
69. R.M. Mitchell, W.M. Freeman, W.T. Randazzo, H.E. Stephens, J.L. Beard, and Z. Simmons A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis Neurology 72 2009 14 19
70. B. Mohammadi, K. Kollewe, A. Samii, K. Krampfl, R. Dengler, and T.F. Munte Changes of resting state brain networks in amyotrophic lateral sclerosis Exp Neurol 217 2009 147 153
71. A. Molfino, I. Kushta, V. Tommasi, F.F. Rossi, and M. Muscaritoli Amyotrophic lateral sclerosis, enteral nutrition and the risk of iron overload J Neurol 256 2009 1015 1016
72. C. Moreau, P. Gosset, V. Brunaud-Danel, P. Lassalle, B. Degonne, and A. Destee CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients Amyotroph Lateral Scler 10 2009 175 181
73. M. Murphy, S. Quinn, J. Young, P. Parkin, and B. Taylor Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study Neurology 71 2008 1889 1895
74. R. Nardin, C. O'Donnell, S.H. Loring, R. Nie, K. Hembre, and J. Walsh Diaphragm training in amyotrophic lateral sclerosis J Clin Neuromuscul Dis 10 2008 56 60
75. Nefussy B, Artamonov I, Deutsch V, Naparstek E, Nagler A, Drory VE. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study. Amyotroph Lateral Scler 2009, doi:10.1080/17482960902933809.
76. S. Nozaki, S. Sugishita, T. Saito, Y. Umaki, K. Adachi, and S. Shinno Prolonged apnea/hypopnea during water swallowing in patients with amyotrophic lateral sclerosis Rinsho Shinkeigaku 48 2008 634 639
77. S. Ohnishi, H. Ito, Y. Suzuki, Y. Adachi, R. Wate, and J. Zhang Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis Brain Res 1296 2009 216 224
78. A. Palmieri, S. Abrahams, G. Soraru, L. Mattiuzzi, C. D'Ascenzo, and E. Pegoraro Emotional lability in MND: Relationship to cognition and psychopathology and impact on caregivers J Neurol Sci 278 2009 16 20
79. J.H. Park, and S.W. Kang Percutaneous radiologic gastrostomy in patients with amyotrophic lateral sclerosis on noninvasive ventilation Arch Phys Med Rehabil 90 2009 1026 1029
80. B.P. Patel, and M.J. Hamadeh Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis Clin Nutr 28 2009 604 617
81. S. Piepers, J.H. Veldink, S.W. de Jong, D.T.I. Van, W.L. van der Pol, and E.V. Uijtendaal Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis Ann Neurol 66 2009 227 234
82. S. Pinto, A. Turkman, A. Pinto, M. Swash, and M. de Carvalho Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies Clin Neurophysiol 120 2009 941 946
83. C. Pizzasegola, I. Caron, C. Daleno, A. Ronchi, C. Minoia, and M.T. Carri Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice Amyotroph Lateral Scler 10 2009 221 228
84. P.F. Pradat, J.P. Camdessanche, L. Carluer, P. Cintas, P. Corcia, and V. Danel-Brunaud Actualités dans la recherche fondamentale et clinique sur la sclérose latérale amyotrophique Rev Neurol (Paris) 165 2009 532 541
85. P.F. Pradat, G. Bruneteau, E. Munerati, F. Salachas, N. Le Forestier, and L. Lacomblez Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis Mov Disord 24 2009 2143 2148
86. P.F. Pradat, G. Bruneteau, and P.H. Gordon Impaired glucose tolerance in patients with amyotrophic lateral sclerosis Amyotroph Lateral Scler 11 2010 166 171
87. P.F. Pradat, and M. Dib Biomarkers in amyotrophic lateral sclerosis: facts and future horizons Mol Diagn Ther 13 2009 1 11
88. M. Qureshi, R.S. Bedlack, and M.E. Cudkowicz Lyme disease serology in amyotrophic lateral sclerosis Muscle Nerve 40 2009 626 628
89. A. Radunovic, D. Annane, K. Jewitt, and N. Mustfa Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease Cochrane Database Syst Rev 2009 CD004427
90. T.S. Reijn, W.F. Abdo, H.J. Schelhaas, and M.M. Verbeek CSF neurofilament protein analysis in the differential diagnosis of ALS J Neurol 256 2009 615 619
91. A.R. Roach, A.J. Averill, S.C. Segerstrom, and E.J. Kasarskis The dynamics of quality of life in ALS patients and caregivers Ann Behav Med 37 2009 197 206
92. C. Rouaux, I. Panteleeva, F. Rene, J.L. Gonzalez de Aguilar, A. Echaniz-Laguna, and L. Dupuis Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model J Neurosci 27 2007 5535 5545
93. S. Saxena, E. Cabuy, and P. Caroni A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice Nat Neurosci 12 2009 627 636
94. E.J. Sorenson, A.J. Windbank, J.N. Mandrekar, W.R. Bamlet, S.H. Appel, and C. Armon Subcutaneous IGF-1 is not beneficial in 2-year ALS trial Neurology 71 2008 1770 1775
95. B.R. Stanton, D. Shinhmar, M.R. Turner, V.C. Williams, S.C. Williams, and C.R. Blain Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosis Arch Neurol 66 2009 109 115
96. P. Steinacker, C. Hendrich, A.D. Sperfeld, S. Jesse, C.A. von Arnim, and S. Lehnert TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis Arch Neurol 65 2008 1481 1487
97. M.J. Strong, G.M. Grace, M. Freedman, C. Lomen-Hoerth, S. Woolley, and L.H. Goldstein Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis Amyotroph Lateral Scler 10 2009 131 146
98. F. Sugai, Y. Yamamoto, K. Miyaguchi, Z. Zhou, H. Sumi, and T. Hamasaki Benefit of valproic acid in suppressing disease progression of ALS model mice Eur J Neurosci 20 2004 3179 3183
99. H. Suzuki, K. Kanekura, T.P. Levine, K. Kohno, V.M. Olkkonen, and S. Aiso ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB J Neurochem 108 2009 973 985
100. H. Takahashi, B.J. Snow, M.H. Bhatt, R. Peppard, A. Eisen, and D.B. Calne Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning Lancet 342 1993 1016 1018
101. L. Thivard, P.F. Pradat, S. Lehericy, L. Lacomblez, D. Dormont, and J. Chiras Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability J Neurol Neurosurg Psychiatry 78 2007 889 892
102. N. Ticozzi, V. Silani, A.L. Leclerc, P. Keagle, C. Gellera, and A. Ratti Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort Neurology 73 2009 1180 1185
103. S. Tsuji-Akimoto, I. Yabe, M. Niino, S. Kikuchi, and H. Sasaki Cystatin C in cerebrospinal fluid as a biomarker of ALS Neurosci Lett 452 2009 52 55
104. M.R. Turner, M.C. Kiernan, P.N. Leigh, and K. Talbot Biomarkers in amyotrophic lateral sclerosis Lancet Neurol 8 2009 94 109
105. N. Vaisman, M. Lusaus, B. Nefussy, E. Niv, D. Comaneshter, and R. Hallack Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J Neurol Sci 279 2009 26 29
106. C. Vance, B. Rogelj, T. Hortobagyi, K.J. De Vos, A.L. Nishimura, and J. Sreedharan Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 Science 323 2009 1208 1211
107. A. Verschueren, A. Monnier, S. Attarian, D. Lardillier, and J. Pouget Enteral and parenteral nutrition in the later stages of ALS: An observational study Amyotroph Lateral Scler 10 2008 42 46
108. S. Vucic, B.C. Cheah, and M.C. Kiernan Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis Exp Neurol 220 2009 177 182
109. L. Wang, K. Sharma, G. Grisotti, and R.P. Roos The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis Neurobiol Dis 35 2009 234 240
110. S. Watanabe, T. Kimura, K. Suenaga, S. Wada, K. Tsuda, and S. Kasama Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis J Neurol Sci 285 2009 146 148
111. I. Wegorzewska, S. Bell, N.J. Cairns, T.M. Miller, and R.H. Baloh TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration Proc Natl Acad Sci U S A 106 2009 18809 18814
112. M.G. Weisskopf, N. Morozova, E.J. O'Reilly, M.L. McCullough, E.E. Calle, and M.J. Thun Prospective study of chemical exposures and amyotrophic lateral sclerosis J Neurol Neurosurg Psychiatry 80 2009 558 561
113. P. Wicks, S. Abrahams, B. Papps, A. al Chalabi, C.E. Shaw, and P.N. Leigh SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis J Neurol 256 2009 234 241
114. Woolley SC, Moore DH, Katz JS. Insight in ALS: Awareness of behavioral change in patients with and without FTD. Amyotroph Lateral Scler 2009 doi:10.1080/17482960903171110.
115. Z. Ying, H. Wang, H. Fan, X. Zhu, J. Zhou, and E. Fei Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation Hum Mol Genet 18 2009 4268 4281
116. T. Zaldivar, J. Gutierrez, G. Lara, M. Carbonara, G. Logroscino, and O. Hardiman Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study Neurology 72 2009 1640 1645
117. Z. Zhong, H. Ilieva, L. Hallagan, R. Bell, I. Singh, and N. Paquette Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells J Clin Invest 119 2009 3437 3449